Maximize merger arbitrage growth returns

Out maneuver the market and identify potential regulatory hurdles for mergers and acquisitions with MLex. Our exclusive market insight, analysis and commentary covers deals from pre-notification through notification, review and approval.

The world's leading hedge funds use the MLex DealRisk service to analyze deals through notification, review, approval and compliance with daily case updates on M&A clearance.

As reported first by MLex

Like to read the full text of these, or any other MLex insights? Request a trial subscription via the form at the bottom of the page.

DuPont, FMC asset-swap deal attracts EU concerns

30 June 2017

Bayer-Monsanto US review hasn't resulted in remedy discussions yet

15 June 2017

Bayer, Mon­santo deal faces in-depth scrutiny in China as Phase 2 review begins

4 May 2017

Key Deals

Our coverage includes exclusive insight and analysis on the following key deals around the globe.

USA

United States of America

Walgreens (WBA)/ Rite Aid (RAD)
AT&T (T)/ Time Warner (TWX)
Dow (DOW)/ DuPont (DD)
Bayer (BAYA)/ Monsanto (MON)
GE (GE)/ Baker Hughes (BHI)
Abbott (ABT)/ Alere (ALR)
Virtu Financial (VIRT)/ KCG Holdings (KCG)

EU

The EU & UK

Dow (DOW)/ DuPont (DD)
Bayer (BAYA)/ Monsanto (MON)
Qualcomm (QCOM)/ NXP (NXP)
Twenty-First Century Fox (FOX)/ Sky (SKY)
Knorr-Bremse (KNO)/ Haldex (HLDX)
Praxair (PX)/ Linde (LIN)
Essilor (EI)/ Luxottica (LUX)
Intel (INTC)/ Mobileye (MBLY)
Atlantia (ATL)/ Abertis (ABE)
John Wood Group (WG) / Amec Foster Wheeler (AMFW)
Tesco (TSCO)/ Booker (BOK)

Asia

Asia

Qualcomm (QCOM)/ NXP (NXP)
Broadcom (AVGO)/ Brocade (BRCD)
ASE (ASX)/ Siliconware (SPIL)
Bayer (BAYA)/ Monsanto (MON)
GE (GE)/ Baker Hughes (BHI)
Maersk Line (MAERSKB) /Hamburg Sud

Latin America

Latin America

Dow (DOW)/ DuPont (DD)
Bayer BAYA)/ Monsanto (MON)
Kroton (KROTY)/ Estacio (ESTC3)
Praxair (PX)/ Linde (LIN)
Essilor (EI)/ Luxottica (LUX)
AT&T (T)/ Time Warner (TWX)
Maersk (MAERSKB) /Hamburg Sud

Request a free MLex trial

Looking for breaking news and to review regulatory implications for specific deals? Complete the form to request a free, limited trial to MLex.